| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1215 | 2019 |
| Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ... Gastroenterology 150 (5), 1147-1159. e5, 2016 | 1188 | 2016 |
| Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ... The Lancet 391 (10138), 2417-2429, 2018 | 540 | 2018 |
| Bile acid-induced liver toxicity: relation to the hydrophobic-hydrophilic balance of bile acids AF Attili, M Angelico, A Cantafora, D Alvaro, L Capocaccia Medical hypotheses 19 (1), 57-69, 1986 | 353 | 1986 |
| Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ... The Lancet Oncology 21 (7), 947-956, 2020 | 290 | 2020 |
| Failure of a reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis M Angelico, D Di Paolo, MO Trinito, A Petrolati, A Araco, S Zazza, ... Hepatology 35 (1), 176-181, 2002 | 230 | 2002 |
| Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis M Angelico, L Carli, C Piat, S Gentile, L Capocaccia Gastroenterology 113 (5), 1632-1639, 1997 | 217 | 1997 |
| Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis M Angelico, L Carli, C Piat, S Gentile, V Rinaldi, E Bologna, L Capocaccia Gastroenterology 104 (5), 1460-1465, 1993 | 188 | 1993 |
| Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence G Tisone, G Orlando, A Cardillo, G Palmieri, TM Manzia, L Baiocchi, ... Journal of hepatology 44 (4), 702-709, 2006 | 175 | 2006 |
| Chronic liver disease in the Alexandria governorate, Egypt: contribution of schistosomiasis and hepatitis virus infections M Angelico, E Renganathan, C Gandin, M Fathy, MC Profili, W Rafai, ... Journal of hepatology 26 (2), 236-243, 1997 | 174 | 1997 |
| Relationships between bile salts hydrophilicity and phospholipid composition in rile of various animal species DAA Cantafora, A Attili, SG Corradini, C De Luca, G Minervini, A DiBiase, ... Comp. Biochem. Physiol 83 (3), 551-554, 1986 | 172 | 1986 |
| Ursodeoxycholate and tauroursodeoxycholate inhibit cholangiocyte growth and secretion of BDL rats through activation of PKC alpha G Alpini, L Baiocchi, S Glaser, Y Ueno, M Marzioni, H Francis, JL Phinizy, ... Hepatology 35 (5), 1041-1052, 2002 | 156 | 2002 |
| Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression R Salpini, L Colagrossi, MC Bellocchi, M Surdo, C Becker, C Alteri, ... Hepatology 61 (3), 823-833, 2015 | 143 | 2015 |
| A randomized controlled trial of pegylated interferon-α2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B P Piccolo, I Lenci, L Demelia, F Bandiera, MR Piras, G Antonucci, ... Antiviral therapy 14 (8), 1165-1174, 2009 | 140 | 2009 |
| Hepatobiliary complications associated with total parenteral nutrition M Angelico, PD Guardia Alimentary pharmacology & therapeutics 14, 54-57, 2000 | 139 | 2000 |
| Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry F Violi, RG Corazza, SH Caldwell, F Perticone, A Gatta, M Angelico, ... Internal and emergency medicine 11, 1059-1066, 2016 | 134 | 2016 |
| Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients M Andreoni, D Goletti, P Pezzotti, A Pozzetto, P Monini, L Sarmati, ... Journal of Infection 43 (3), 195-199, 2001 | 134 | 2001 |
| 13C‐methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation A Petrolati, D Festi, G De Berardinis, L Colaiocco‐Ferrante, D Di Paolo, ... Alimentary pharmacology & therapeutics 18 (8), 785-790, 2003 | 118 | 2003 |
| Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone … N Figura, F Cetta, M Angelico, G Montalto, D Cetta, L Pacenti, C Vindigni, ... Digestive diseases and sciences 43, 854-862, 1998 | 118 | 1998 |
| HCV genotypes are differently prone to the development of resistance to linear and macrocyclic protease inhibitors V Cento, C Mirabelli, R Salpini, S Dimonte, A Artese, G Costa, F Mercurio, ... PloS one 7 (7), e39652, 2012 | 111 | 2012 |
